Medicare Enrolled

Dr. Janet Englund

Pediatric Infectious Diseases Physician · Seattle, WA
Consulting-driven
4800 SAND POINT WAY NE, Seattle, WA 98105
2069872000
In practice since 2006 (19 years)
NPI: 1679663561 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Englund from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Englund? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Englund

Dr. Janet Englund is a pediatric infectious diseases physician in Seattle, WA, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Englund received a total of $175,164 from 14 pharmaceutical and/or device companies across 116 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric infectious diseases physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Englund is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $175,164 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$175,164
Total received (2018-2024)
Avg $25,023/year across 7 years
Top 0% in WA for pediatric infectious diseases physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
14
Companies
116
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$134,306 (76.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$39,659 (22.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,200 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$78,787
2023
$6,047
2022
$24,574
2021
$16,752
2020
$13,685
2019
$17,280
2018
$18,040

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ModernaTX, Inc.
$43,797
PFIZER INC.
$22,993
Merck Sharp & Dohme LLC
$4,891
GlaxoSmithKline, LLC.
$4,550
PFIZER INTERNATIONAL LLC
$1,455
AstraZeneca Pharmaceuticals LP
$1,100
Top 3 companies account for 91.0% of 2024 payments
All-time payments by company (2018-2024) ›
ModernaTX, Inc.
$45,397
PFIZER INC.
$24,290
SANOFI PASTEUR INC.
$22,214
AstraZeneca UK Limited
$21,322
Sanofi Pasteur Inc.
$16,290
Merck Sharp & Dohme Corporation
$9,891
GlaxoSmithKline, LLC.
$9,282
AstraZeneca Pharmaceuticals LP
$5,794
Merck Sharp & Dohme LLC
$4,891
Teva Pharmaceuticals USA, Inc.
$4,225
Genentech, Inc.
$4,202
ABBVIE INC.
$3,750
Janssen Global Services, LLC
$2,160
PFIZER INTERNATIONAL LLC
$1,455
Top 3 companies account for 52.5% of all-time payments
Associated products mentioned in payments ›
ABRYSVO · EVUSHELD · FLUMIST · FLUMIST QUADRIVALENT · MK-4482 · Moderna Covid-19 Vaccine · NO PRODUCT DISCUSSED · PAXLOVID · PREVYMIS · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (77%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for pediatric infectious diseases physician in WA.

Looking for a pediatric infectious diseases physician in Seattle?
Compare pediatric infectious diseases physicians in the Seattle area by procedure volume, costs, and industry payment transparency.
Browse pediatric infectious diseases physicians nearby

Geographic Context

Pediatric infectious diseases physicians within 10 mi
26
Per 100K population
1.1
County median income
$122,148
Nearest hospital
SEATTLE CHILDREN'S HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Englund is a pediatric infectious diseases physician, with consulting-driven industry engagement in the top 0% of WA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Englund receive payments from pharmaceutical companies?
Yes. Dr. Englund received a total of $175,164 from 14 companies across 116 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Englund) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →